Richard Auburn
Directeur/Membre du Conseil chez Singula Bio Ltd.
Postes actifs de Richard Auburn
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Oxford University Innovation Ltd.
 Oxford University Innovation Ltd. Investment ManagersFinance Oxford University Innovation Ltd (Oxford University Innovation) is a venture capital subsidiary of University of Oxford founded in 1987 and spun out in 2010. The firm is headquartered in London, United Kingdom. | Private Equity Investor | 01/01/2015 | - |
Singula Bio Ltd.
 Singula Bio Ltd. BiotechnologyHealth Technology Singula Bio Ltd. is a seed-stage biotechnology company based in Oxford, UK. The British company was spun out of the University of Oxford and is focused on developing novel neoantigen-based cell therapies for patients with solid tumors. The company was founded by Vincenzo Cerundolo, Enda McVeigh, Ahmed Ahmed. | Directeur/Membre du Conseil | 01/11/2020 | - |
Historique de carrière de Richard Auburn
Formation de Richard Auburn
| University of Cambridge | Graduate Degree |
| University of Aberdeen | Undergraduate Degree |
Statistiques
Internationale
| Royaume-Uni | 5 |
Opérationnelle
| Private Equity Investor | 1 |
| Director/Board Member | 1 |
| Graduate Degree | 1 |
Sectorielle
| Consumer Services | 3 |
| Finance | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Oxford University Innovation Ltd.
Oxford University Innovation Ltd. Investment ManagersFinance Oxford University Innovation Ltd (Oxford University Innovation) is a venture capital subsidiary of University of Oxford founded in 1987 and spun out in 2010. The firm is headquartered in London, United Kingdom. | Finance |
Singula Bio Ltd.
Singula Bio Ltd. BiotechnologyHealth Technology Singula Bio Ltd. is a seed-stage biotechnology company based in Oxford, UK. The British company was spun out of the University of Oxford and is focused on developing novel neoantigen-based cell therapies for patients with solid tumors. The company was founded by Vincenzo Cerundolo, Enda McVeigh, Ahmed Ahmed. | Health Technology |
- Bourse
- Insiders
- Richard Auburn
- Expérience
